ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2014

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.

Yevgeniy Samyshkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.